The  ||| S:0 E:4 ||| DT
association  ||| S:4 E:16 ||| NN
between  ||| S:16 E:24 ||| IN
dietary  ||| S:24 E:32 ||| JJ
inflammatory  ||| S:32 E:45 ||| JJ
index  ||| S:45 E:51 ||| NN
and  ||| S:51 E:55 ||| CC
risk  ||| S:55 E:60 ||| NN
of  ||| S:60 E:63 ||| IN
colorectal  ||| S:63 E:74 ||| JJ
cancer  ||| S:74 E:81 ||| NN
among  ||| S:81 E:87 ||| IN
postmenopausal  ||| S:87 E:102 ||| JJ
women ||| S:102 E:107 ||| NNS
:  ||| S:107 E:109 ||| :
results  ||| S:109 E:117 ||| NNS
from  ||| S:117 E:122 ||| IN
the  ||| S:122 E:126 ||| DT
Women ||| S:126 E:131 ||| NNP
's  ||| S:131 E:134 ||| POS
Health  ||| S:134 E:141 ||| NNP
Initiative  ||| S:141 E:152 ||| NNP
Inflammation  ||| S:152 E:165 ||| NNP
is  ||| S:165 E:168 ||| VBZ
a  ||| S:168 E:170 ||| DT
process  ||| S:170 E:178 ||| NN
central  ||| S:178 E:186 ||| JJ
to  ||| S:186 E:189 ||| TO
carcinogenesis  ||| S:189 E:204 ||| VB
and  ||| S:204 E:208 ||| CC
in  ||| S:208 E:211 ||| IN
particular  ||| S:211 E:222 ||| JJ
to  ||| S:222 E:225 ||| TO
colorectal  ||| S:225 E:236 ||| VB
cancer  ||| S:236 E:243 ||| NN
( ||| S:243 E:244 ||| -LRB-
CRC ||| S:244 E:247 ||| NNP
) ||| S:247 E:248 ||| -RRB-
.  ||| S:248 E:250 ||| .
Previously ||| S:250 E:260 ||| RB
,  ||| S:260 E:262 ||| ,
we  ||| S:262 E:265 ||| PRP
developed  ||| S:265 E:275 ||| VBD
a  ||| S:275 E:277 ||| DT
dietary  ||| S:277 E:285 ||| JJ
inflammatory  ||| S:285 E:298 ||| JJ
index  ||| S:298 E:304 ||| NN
( ||| S:304 E:305 ||| -LRB-
DII ||| S:305 E:308 ||| NNP
)  ||| S:308 E:310 ||| -RRB-
from  ||| S:310 E:315 ||| IN
extensive  ||| S:315 E:325 ||| JJ
literature  ||| S:325 E:336 ||| NN
review  ||| S:336 E:343 ||| NN
to  ||| S:343 E:346 ||| TO
assess  ||| S:346 E:353 ||| VB
the  ||| S:353 E:357 ||| DT
inflammatory  ||| S:357 E:370 ||| JJ
potential  ||| S:370 E:380 ||| NN
of  ||| S:380 E:383 ||| IN
diet ||| S:383 E:387 ||| NN
.  ||| S:387 E:389 ||| .
In  ||| S:389 E:392 ||| IN
the  ||| S:392 E:396 ||| DT
current  ||| S:396 E:404 ||| JJ
study ||| S:404 E:409 ||| NN
,  ||| S:409 E:411 ||| ,
we  ||| S:411 E:414 ||| PRP
utilized  ||| S:414 E:423 ||| VBD
this  ||| S:423 E:428 ||| DT
novel  ||| S:428 E:434 ||| NN
index  ||| S:434 E:440 ||| NN
in  ||| S:440 E:443 ||| IN
the  ||| S:443 E:447 ||| DT
Women ||| S:447 E:452 ||| NNP
's  ||| S:452 E:455 ||| POS
Health  ||| S:455 E:462 ||| NNP
Initiative  ||| S:462 E:473 ||| NNP
to  ||| S:473 E:476 ||| TO
prospectively  ||| S:476 E:490 ||| RB
evaluate  ||| S:490 E:499 ||| VB
its  ||| S:499 E:503 ||| PRP$
association  ||| S:503 E:515 ||| NN
with  ||| S:515 E:520 ||| IN
risk  ||| S:520 E:525 ||| NN
of  ||| S:525 E:528 ||| IN
CRC  ||| S:528 E:532 ||| NNP
in  ||| S:532 E:535 ||| IN
postmenopausal  ||| S:535 E:550 ||| JJ
women ||| S:550 E:555 ||| NNS
.  ||| S:555 E:557 ||| .
The  ||| S:557 E:561 ||| DT
DII  ||| S:561 E:565 ||| NNP
was  ||| S:565 E:569 ||| VBD
calculated  ||| S:569 E:580 ||| VBN
from  ||| S:580 E:585 ||| IN
baseline  ||| S:585 E:594 ||| JJ
food  ||| S:594 E:599 ||| NN
frequency  ||| S:599 E:609 ||| NN
questionnaires  ||| S:609 E:624 ||| VBZ
administered  ||| S:624 E:637 ||| VBN
to  ||| S:637 E:640 ||| TO
152,536  ||| S:640 E:648 ||| CD
women  ||| S:648 E:654 ||| NNS
aged  ||| S:654 E:659 ||| VBN
50-79 years  ||| S:659 E:671 ||| CD
without  ||| S:671 E:679 ||| IN
CRC  ||| S:679 E:683 ||| NNP
at  ||| S:683 E:686 ||| IN
baseline  ||| S:686 E:695 ||| NN
between  ||| S:695 E:703 ||| IN
1993  ||| S:703 E:708 ||| CD
and  ||| S:708 E:712 ||| CC
1998  ||| S:712 E:717 ||| CD
and  ||| S:717 E:721 ||| CC
followed  ||| S:721 E:730 ||| VBN
through  ||| S:730 E:738 ||| IN
30  ||| S:738 E:741 ||| CD
September  ||| S:741 E:751 ||| NNP
2010 ||| S:751 E:755 ||| CD
.  ||| S:755 E:757 ||| .
Incident  ||| S:757 E:766 ||| NNP
CRC  ||| S:766 E:770 ||| NNP
cases  ||| S:770 E:776 ||| NNS
were  ||| S:776 E:781 ||| VBD
ascertained  ||| S:781 E:793 ||| VBN
through  ||| S:793 E:801 ||| IN
a  ||| S:801 E:803 ||| DT
central  ||| S:803 E:811 ||| JJ
physician  ||| S:811 E:821 ||| NN
adjudication  ||| S:821 E:834 ||| NN
process ||| S:834 E:841 ||| NN
.  ||| S:841 E:843 ||| .
Multiple  ||| S:843 E:852 ||| NNP
covariate-adjusted  ||| S:852 E:871 ||| NNP
Cox  ||| S:871 E:875 ||| NNP
proportional  ||| S:875 E:888 ||| JJ
hazards  ||| S:888 E:896 ||| NNS
regression  ||| S:896 E:907 ||| JJ
models  ||| S:907 E:914 ||| NNS
were  ||| S:914 E:919 ||| VBD
used  ||| S:919 E:924 ||| VBN
to  ||| S:924 E:927 ||| TO
estimate  ||| S:927 E:936 ||| VB
hazard  ||| S:936 E:943 ||| JJ
ratios  ||| S:943 E:950 ||| NNS
( ||| S:950 E:951 ||| -LRB-
HR ||| S:951 E:953 ||| NNP
)  ||| S:953 E:955 ||| -RRB-
and  ||| S:955 E:959 ||| CC
95  ||| S:959 E:962 ||| CD
%  ||| S:962 E:964 ||| NN
confidence  ||| S:964 E:975 ||| NN
intervals  ||| S:975 E:985 ||| NNS
( ||| S:985 E:986 ||| -LRB-
95  ||| S:986 E:989 ||| NNP
%  ||| S:989 E:991 ||| NN
CI ||| S:991 E:993 ||| NNP
)  ||| S:993 E:995 ||| -RRB-
for  ||| S:995 E:999 ||| IN
colorectal ||| S:999 E:1009 ||| NN
,  ||| S:1009 E:1011 ||| ,
colon  ||| S:1011 E:1017 ||| NN
( ||| S:1017 E:1018 ||| -LRB-
proximal ||| S:1018 E:1026 ||| FW
/ ||| S:1026 E:1027 ||| FW
distal  ||| S:1027 E:1034 ||| FW
locations ||| S:1034 E:1043 ||| FW
) ||| S:1043 E:1044 ||| -RRB-
,  ||| S:1044 E:1046 ||| ,
and  ||| S:1046 E:1050 ||| CC
rectal  ||| S:1050 E:1057 ||| JJ
cancer  ||| S:1057 E:1064 ||| NN
risk ||| S:1064 E:1068 ||| NN
,  ||| S:1068 E:1070 ||| ,
by  ||| S:1070 E:1073 ||| IN
DII  ||| S:1073 E:1077 ||| NNP
quintiles  ||| S:1077 E:1087 ||| NNS
( ||| S:1087 E:1088 ||| -LRB-
Q ||| S:1088 E:1089 ||| NNP
) ||| S:1089 E:1090 ||| -RRB-
.  ||| S:1090 E:1092 ||| .
During  ||| S:1092 E:1099 ||| IN
an  ||| S:1099 E:1102 ||| DT
average  ||| S:1102 E:1110 ||| JJ
11.3 years  ||| S:1110 E:1121 ||| NN
of  ||| S:1121 E:1124 ||| IN
follow-up ||| S:1124 E:1133 ||| NNP
,  ||| S:1133 E:1135 ||| ,
a  ||| S:1135 E:1137 ||| DT
total  ||| S:1137 E:1143 ||| NN
of  ||| S:1143 E:1146 ||| IN
1,920  ||| S:1146 E:1152 ||| CD
cases  ||| S:1152 E:1158 ||| NNS
of  ||| S:1158 E:1161 ||| IN
CRC  ||| S:1161 E:1165 ||| NNP
( ||| S:1165 E:1166 ||| -LRB-
1,559  ||| S:1166 E:1172 ||| NNP
colon  ||| S:1172 E:1178 ||| NN
and  ||| S:1178 E:1182 ||| CC
361  ||| S:1182 E:1186 ||| CD
rectal ||| S:1186 E:1192 ||| CD
)  ||| S:1192 E:1194 ||| -RRB-
were  ||| S:1194 E:1199 ||| VBD
identified ||| S:1199 E:1209 ||| VBN
.  ||| S:1209 E:1211 ||| .
Higher  ||| S:1211 E:1218 ||| RBR
DII  ||| S:1218 E:1222 ||| JJ
scores  ||| S:1222 E:1229 ||| NNS
( ||| S:1229 E:1230 ||| -LRB-
representing  ||| S:1230 E:1243 ||| VBG
a  ||| S:1243 E:1245 ||| DT
more  ||| S:1245 E:1250 ||| RBR
pro-inflammatory  ||| S:1250 E:1267 ||| JJ
diet ||| S:1267 E:1271 ||| NN
)  ||| S:1271 E:1273 ||| -RRB-
were  ||| S:1273 E:1278 ||| VBD
associated  ||| S:1278 E:1289 ||| VBN
with  ||| S:1289 E:1294 ||| IN
an  ||| S:1294 E:1297 ||| DT
increased  ||| S:1297 E:1307 ||| JJ
incidence  ||| S:1307 E:1317 ||| NN
of CRC  ||| S:1317 E:1324 ||| NNP
( ||| S:1324 E:1325 ||| -LRB-
HRQ5-Q1  ||| S:1325 E:1333 ||| CD
1.22 ||| S:1333 E:1337 ||| CD
;  ||| S:1337 E:1339 ||| :
95  ||| S:1339 E:1342 ||| CD
%  ||| S:1342 E:1344 ||| NN
CI  ||| S:1344 E:1347 ||| NNP
1.05 ||| S:1347 E:1351 ||| CD
,  ||| S:1351 E:1353 ||| ,
1.43 ||| S:1353 E:1357 ||| CD
;  ||| S:1357 E:1359 ||| :
p  ||| S:1359 E:1361 ||| CD
trend = 0.02 ||| S:1361 E:1373 ||| CD
)  ||| S:1373 E:1375 ||| -RRB-
and  ||| S:1375 E:1379 ||| CC
colon  ||| S:1379 E:1385 ||| NN
cancer ||| S:1385 E:1391 ||| NN
,  ||| S:1391 E:1393 ||| ,
specifically  ||| S:1393 E:1406 ||| RB
proximal  ||| S:1406 E:1415 ||| JJ
colon  ||| S:1415 E:1421 ||| NN
cancer  ||| S:1421 E:1428 ||| NN
( ||| S:1428 E:1429 ||| -LRB-
HRQ5-Q1  ||| S:1429 E:1437 ||| CD
1.35 ||| S:1437 E:1441 ||| CD
;  ||| S:1441 E:1443 ||| :
95  ||| S:1443 E:1446 ||| CD
%  ||| S:1446 E:1448 ||| NN
CI  ||| S:1448 E:1451 ||| NNP
1.05 ||| S:1451 E:1455 ||| CD
,  ||| S:1455 E:1457 ||| ,
1.67 ||| S:1457 E:1461 ||| CD
;  ||| S:1461 E:1463 ||| :
p  ||| S:1463 E:1465 ||| CD
trend = 0.01 ||| S:1465 E:1477 ||| CD
)  ||| S:1477 E:1479 ||| -RRB-
but  ||| S:1479 E:1483 ||| CC
not  ||| S:1483 E:1487 ||| RB
distal  ||| S:1487 E:1494 ||| JJ
colon  ||| S:1494 E:1500 ||| NN
cancer  ||| S:1500 E:1507 ||| NN
( ||| S:1507 E:1508 ||| -LRB-
HRQ5-Q1  ||| S:1508 E:1516 ||| CD
0.84 ||| S:1516 E:1520 ||| CD
;  ||| S:1520 E:1522 ||| :
95  ||| S:1522 E:1525 ||| CD
%  ||| S:1525 E:1527 ||| NN
CI  ||| S:1527 E:1530 ||| NNP
0.61 ||| S:1530 E:1534 ||| NNP
,  ||| S:1534 E:1536 ||| ,
1.18 ||| S:1536 E:1540 ||| CD
;  ||| S:1540 E:1542 ||| :
p  ||| S:1542 E:1544 ||| CD
trend = 0.63 ||| S:1544 E:1556 ||| CD
)  ||| S:1556 E:1558 ||| -RRB-
or  ||| S:1558 E:1561 ||| CC
rectal  ||| S:1561 E:1568 ||| JJ
cancer  ||| S:1568 E:1575 ||| NN
( ||| S:1575 E:1576 ||| -LRB-
HRQ5-Q1  ||| S:1576 E:1584 ||| CD
1.20 ||| S:1584 E:1588 ||| CD
;  ||| S:1588 E:1590 ||| :
95  ||| S:1590 E:1593 ||| CD
%  ||| S:1593 E:1595 ||| NN
CI  ||| S:1595 E:1598 ||| NNP
0.84 ||| S:1598 E:1602 ||| NNP
,  ||| S:1602 E:1604 ||| ,
1.72 ||| S:1604 E:1608 ||| CD
;  ||| S:1608 E:1610 ||| :
p  ||| S:1610 E:1612 ||| CD
trend = 0.65 ||| S:1612 E:1624 ||| CD
) ||| S:1624 E:1625 ||| -RRB-
.  ||| S:1625 E:1627 ||| .
Consumption  ||| S:1627 E:1639 ||| NN
of  ||| S:1639 E:1642 ||| IN
pro-inflammatory  ||| S:1642 E:1659 ||| JJ
diets  ||| S:1659 E:1665 ||| NN
is  ||| S:1665 E:1668 ||| VBZ
associated  ||| S:1668 E:1679 ||| VBN
with  ||| S:1679 E:1684 ||| IN
an  ||| S:1684 E:1687 ||| DT
increased  ||| S:1687 E:1697 ||| JJ
risk  ||| S:1697 E:1702 ||| NN
of  ||| S:1702 E:1705 ||| IN
CRC ||| S:1705 E:1708 ||| NNP
,  ||| S:1708 E:1710 ||| ,
especially  ||| S:1710 E:1721 ||| RB
cancers  ||| S:1721 E:1729 ||| VB
located  ||| S:1729 E:1737 ||| VBN
in  ||| S:1737 E:1740 ||| IN
the  ||| S:1740 E:1744 ||| DT
proximal  ||| S:1744 E:1753 ||| JJ
colon ||| S:1753 E:1758 ||| NN
.  ||| S:1758 E:1760 ||| .
The  ||| S:1760 E:1764 ||| DT
absence  ||| S:1764 E:1772 ||| NN
of  ||| S:1772 E:1775 ||| IN
a  ||| S:1775 E:1777 ||| DT
significant  ||| S:1777 E:1789 ||| JJ
association  ||| S:1789 E:1801 ||| NN
for  ||| S:1801 E:1805 ||| IN
distal  ||| S:1805 E:1812 ||| JJ
colon  ||| S:1812 E:1818 ||| NN
cancer  ||| S:1818 E:1825 ||| NN
and  ||| S:1825 E:1829 ||| CC
rectal  ||| S:1829 E:1836 ||| JJ
cancer  ||| S:1836 E:1843 ||| NN
may  ||| S:1843 E:1847 ||| MD
be  ||| S:1847 E:1850 ||| VB
due  ||| S:1850 E:1854 ||| JJ
to  ||| S:1854 E:1857 ||| TO
the  ||| S:1857 E:1861 ||| DT
small  ||| S:1861 E:1867 ||| JJ
number  ||| S:1867 E:1874 ||| NN
of  ||| S:1874 E:1877 ||| IN
incident  ||| S:1877 E:1886 ||| NN
cases  ||| S:1886 E:1892 ||| NNS
for  ||| S:1892 E:1896 ||| IN
these  ||| S:1896 E:1902 ||| DT
sites ||| S:1902 E:1907 ||| NNS
.  ||| S:1907 E:1909 ||| .
Interventions  ||| S:1909 E:1923 ||| NNS
that  ||| S:1923 E:1928 ||| WDT
may  ||| S:1928 E:1932 ||| MD
reduce  ||| S:1932 E:1939 ||| VB
the  ||| S:1939 E:1943 ||| DT
inflammatory  ||| S:1943 E:1956 ||| JJ
potential  ||| S:1956 E:1966 ||| NN
of  ||| S:1966 E:1969 ||| IN
the  ||| S:1969 E:1973 ||| DT
diet  ||| S:1973 E:1978 ||| NN
are  ||| S:1978 E:1982 ||| VBP
warranted  ||| S:1982 E:1992 ||| VBN
to  ||| S:1992 E:1995 ||| TO
test  ||| S:1995 E:2000 ||| VB
our  ||| S:2000 E:2004 ||| PRP$
findings ||| S:2004 E:2012 ||| NNS
,  ||| S:2012 E:2014 ||| ,
thus  ||| S:2014 E:2019 ||| RB
providing  ||| S:2019 E:2029 ||| VBG
more  ||| S:2029 E:2034 ||| JJR
information  ||| S:2034 E:2046 ||| NN
for  ||| S:2046 E:2050 ||| IN
colon  ||| S:2050 E:2056 ||| NN
cancer  ||| S:2056 E:2063 ||| NN
prevention ||| S:2063 E:2073 ||| NN
.  ||| S:2073 E:2075 ||| .
